Investigation of Muscle Disease
JNNP 60:256-274, Mastaglia,F.L.&Laing,N.G., 1996
Duchenne Muscular Dystrophy
BMJ 368:L7012, Fox, H.,et al, 2020
Heterogeneity of Coenzyme Q10 Deficiency
Arch Neurol 69:978-983, Emmanuele, V.,et al, 2012
Toxic and Drug-Induced Myopathies
JNNP 80:832-838, Dalakas,M.C., 2009
Malignant Hyperthermia, Update on Susceptibility Testing
JAMA 293:2918-2924,2958, Litman,R.S.&Rosenberg,H., 2005
AAC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Stroke 33:2337-2341, Pasternak,R.C.,et al, 2002
Clinicopath Conf, Strychnine Poisoning, Case 12-2001
NEJM 344:1232-1239, , 2001
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Sustained Myoglobinuria:The Presenting Manifestation of Dermatomyositis
Neurol 47:119-123, Rose,M.R.,et al, 1996
The Neuromuscular Manifestations of Human Immunodeficiency Virus Infections
Arch Neurol 45:1084-1088, Lange,D.J.,et al, 1988
Severe Dystonia & Myoglobinuria
Neurol 32:1195-1197, Jankovic,J.,et al, 1982
Myositis, Myoglobinemia, & Myoglobinuria Associated With Enterovirus Echo 9 Infection
Arch Neurol 37:457-458, Jehn,U.W.,et al, 1980